Elevation Oncology (ELEV) director Clackson gifted 15,777 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Timothy P Clackson (director at Elevation Oncology Inc., ELEV) reported that they gifted 15,777 shares on Sep 1, 2023. After these transactions the filing shows 0 shares held directly.
- Reporting person
- Clackson Timothy P
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 1, 2023 | Gift (G) | Common Stock1 | -15,777 | - | - | 0 direct |
Holdings before and after
- Common Stock: 15,777 to 0 direct
Other positions listed
- Common Stock: 47,330 indirect, The Timothy P. Clackson Irrevocable GST Trust of 2020
Footnotes from the filing
- 1. On September 1, 2023, the Reporting Person transferred 15,777 shares of the Issuer's Common Stock to The Timothy P. Clackson Irrevocable GST Trust of 2020, of which the Reporting Person is the grantor. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust.
Transaction codes in this filing
- Gift:
- Code G marks a bona fide gift. No money changes hands.
FAQ
What did Clackson report in this ELEV Form 4?
Timothy P Clackson (director at Elevation Oncology Inc., ELEV) reported that they gifted 15,777 shares on Sep 1, 2023. After these transactions the filing shows 0 shares held directly.
How many ELEV shares does Clackson hold after this filing?
The filing shows 0 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code G mean on an SEC Form 4?
Code G marks a bona fide gift. No money changes hands.
Historical context for ELEV
Earlier insider filings at ELEV
- Jul 14, 2023SEC Form 4 filed by Furlong Tammy
- Jul 14, 2023SEC Form 4 filed by Ferra Joseph J Jr
- Jun 21, 2023SEC Form 4 filed by Walsh Colin
- Jun 21, 2023SEC Form 4 filed by Hu Lori
- Jun 21, 2023SEC Form 4 filed by Clackson Timothy P
Keep researching ELEV
- ELEV insider tradesEvery buy and sale reported by Elevation Oncology Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
ELEV
Elevation Oncology Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for ELEV
Full ELEV profile on Quantisnow Follow ELEV and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time